Delivery Order SPE2DB20D2001-SPE2DB21FM50N
Award Date 6/8/21
Potential Completion Date 6/9/21
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $1,841.30 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, with an ultimate completion date of April 24, 2023, is structured as a firm fixed-price Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,161.90 delivery order for 4,554,472,760 units of the medication Vyvanse 60 mg capsules. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Vyvanse 50 mg capsules, to support government healthcare programs. The $4,628.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00. The contract covers the delivery of 4,563,617,369 units of Vyvanse 30 mg capsules, a specialty medication, to support military and veterans' healthcare programs. The award has a ceiling value of $1,755.19 and an ultimate completion date of February 12, 2024. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,898.85, is for the delivery of Vyvanse 50 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FV6A4) valued at $1,271.42 for the supply of Vyvanse 20 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,671.84 for the supply of Vyvanse 30 mg capsule. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
- This federal contract award, valued at $1,724.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 4564398222 - Vyvanse 20 mg capsules, with an ultimate completion date of April 26, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,594.94 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 20 mg capsules. The $2,782.01 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...